FTI
71
-7
MUR
44
-3
DG
8
-2
MAS
52
-4
GM
74
5
PG
50
2
SWKS
38
-2
VNO
46
-13
TGNA
50
-6
IRM
41
3
NEE
54
7
EXR
57
2
D
40
2
SYY
49
9
GT
56
-3
CPB
22
-5
PEG
62
4
HST
39
-3
NWSA
62
-7
SBUX
37
-2
FTI
71
-7
MUR
44
-3
DG
8
-2
MAS
52
-4
GM
74
5
PG
50
2
SWKS
38
-2
VNO
46
-13
TGNA
50
-6
IRM
41
3
NEE
54
7
EXR
57
2
D
40
2
SYY
49
9
GT
56
-3
CPB
22
-5
PEG
62
4
HST
39
-3
NWSA
62
-7
SBUX
37
-2
Financhill
Back

ProShares Ultra Gold Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
45

UGL
ProShares Ultra Gold

Last Price:
89.85
Seasonality Move:
3.81%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
45
ProShares Ultra Gold (UGL) is a Sell

Is ProShares Ultra Gold a Buy, Sell or Hold?

  • The current ProShares Ultra Gold [UGL] share price is $89.87. The Score for UGL is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • UGL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

UGL Stock Price Chart

What is ProShares Ultra Gold's stock price today?

  • The ProShares Ultra Gold share price today is $89.87
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and UGL is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

UGL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.81 Sell
Relative Strength Index (14 RSI): 32.25 Sell
Chaikin Money Flow: -150415 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (94.95 - 104.59) Sell
Bollinger Bands (100): (82.25 - 98.43) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

UGL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 94.3 Sell
20-day SMA: 99.92 Sell
50-day SMA: 97.19 Sell
200-day SMA: 81.9 Buy
8-day EMA: 93.9 Sell
20-day EMA: 97.17 Sell
50-day EMA: 96.06 Sell
200-day EMA: 83.91 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

ProShares Ultra Gold Earnings Growth & UGL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

ProShares Ultra Gold Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):